Bone loss often occurs as a side effect in men who receive hormone-deprivation therapy for their advanced prostate cancer.
However, according to a new study, bone-strengthening drugs Fosamax may help to avoid the damage.
Earlier it was found that the drug prevent bone loss in patients on hormone-deprivation therapy. And now the current follow-up shows that two […]















































